OPKO Health Long Term Debt 2010-2024 | OPK

OPKO Health long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
OPKO Health Annual Long Term Debt
(Millions of US $)
2023 $214
2022 $210
2021 $188
2020 $222
2019 $211
2018 $57
2017 $29
2016 $44
2015 $49
2014 $131
2013 $212
2012 $
2011 $25
2010 $
2009 $15
OPKO Health Quarterly Long Term Debt
(Millions of US $)
2024-06-30 $176
2024-03-31 $344
2023-12-31 $214
2023-09-30 $213
2023-06-30 $212
2023-03-31 $211
2022-12-31 $210
2022-09-30 $142
2022-06-30 $211
2022-03-31 $211
2021-12-31 $188
2021-09-30 $186
2021-06-30 $183
2021-03-31 $225
2020-12-31 $222
2020-09-30 $219
2020-06-30 $216
2020-03-31 $214
2019-12-31 $211
2019-09-30 $209
2019-06-30 $206
2019-03-31 $204
2018-12-31 $57
2018-09-30 $57
2018-06-30 $56
2018-03-31 $55
2017-12-31 $29
2017-09-30 $29
2017-06-30 $35
2017-03-31 $39
2016-12-31 $44
2016-09-30 $52
2016-06-30 $45
2016-03-31 $50
2015-12-31 $49
2015-09-30 $44
2015-06-30 $109
2015-03-31 $107
2014-12-31 $131
2014-09-30 $115
2014-06-30 $116
2014-03-31 $225
2013-12-31 $212
2013-09-30 $209
2013-06-30 $189
2013-03-31 $276
2012-12-31
2012-09-30 $33
2012-06-30 $23
2012-03-31 $22
2011-12-31 $25
2011-09-30 $2
2011-06-30 $2
2011-03-31 $2
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31 $15
2009-09-30 $15
2009-06-30 $14
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.025B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.078B 26.12
Intuitive Surgical (ISRG) United States $183.628B 96.01
Alcon (ALC) Switzerland $45.117B 31.76
IQVIA Holdings (IQV) United States $40.157B 22.12
Edwards Lifesciences (EW) United States $39.608B 24.62
IDEXX Laboratories (IDXX) United States $34.672B 40.83
DexCom (DXCM) United States $26.799B 40.36
Waters (WAT) United States $22.960B 33.95
STERIS (STE) Ireland $22.437B 25.85
SONOVA HOLDING (SONVY) Switzerland $21.922B 0.00
Hologic (HOLX) United States $18.696B 19.73
Fresenius Medical Care AG KGaA (FMS) Germany $12.376B 12.70
Sysmex ADR (SSMXY) Japan $11.851B 37.16
Globus Medical (GMED) United States $11.200B 28.52
Teleflex (TFX) United States $9.378B 14.96
Penumbra (PEN) United States $8.969B 87.86
Masimo (MASI) United States $8.917B 43.43
Glaukos (GKOS) United States $7.755B 0.00
PROCEPT BioRobotics (PRCT) United States $5.126B 0.00
Integer Holdings (ITGR) United States $4.542B 25.75
Inari Medical (NARI) United States $3.119B 0.00
TransMedics (TMDX) United States $2.898B 91.86
LivaNova (LIVN) United Kingdom $2.829B 16.33
Veracyte (VCYT) United States $2.811B 85.09
Nihon Kohden (NHNKY) Japan $2.519B 15.68
Tandem Diabetes Care (TNDM) United States $2.242B 0.00
Elekta AB (EKTAY) Sweden $2.227B 18.14
Integra LifeSciences Holdings (IART) United States $2.060B 10.77
RxSight (RXST) United States $2.024B 0.00
Alphatec Holdings (ATEC) United States $1.257B 0.00
Artivion (AORT) United States $1.233B 113.23
Pulse Biosciences (PLSE) United States $1.110B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.963B 16.37
OrthoPediatrics (KIDS) United States $0.749B 0.00
Mesa Laboratories (MLAB) United States $0.726B 18.33
Pacific Biosciences Of California (PACB) United States $0.722B 0.00
IRadimed (IRMD) United States $0.712B 38.49
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
AxoGen (AXGN) United States $0.672B 0.00
SiBone (SIBN) United States $0.669B 0.00
Paragon 28 (FNA) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.485B 0.00
CVRx (CVRX) United States $0.374B 0.00
ClearPoint Neuro (CLPT) United States $0.369B 0.00
Tactile Systems Technology (TCMD) United States $0.351B 18.99
Delcath Systems (DCTH) United States $0.304B 0.00
AngioDynamics (ANGO) United States $0.301B 0.00
Semler Scientific (SMLR) United States $0.291B 19.57
Sight Sciences (SGHT) United States $0.257B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
Inogen (INGN) United States $0.227B 0.00
Nevro (NVRO) United States $0.216B 0.00
Accuray (ARAY) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.186B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
908 Devices (MASS) United States $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.129B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.110B 16.32
EDAP TMS S.A (EDAP) France $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Accelerate Diagnostics (AXDX) United States $0.047B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.038B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Biosig Technologies (BSGM) United States $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.019B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00